Is opportunistic disease prevention in the consultation ethically justifiable?
作者信息
Getz Linn, Sigurdsson Johann A, Hetlevik Irene
机构信息
Office of Human Resources, Landspitali University Hospital, IS-101 Reykjavík, Iceland.
出版信息
BMJ. 2003 Aug 30;327(7413):498-500. doi: 10.1136/bmj.327.7413.498.
Abstract
摘要
相似文献
1
Is opportunistic disease prevention in the consultation ethically justifiable?
BMJ. 2003 Aug 30;327(7413):498-500. doi: 10.1136/bmj.327.7413.498.
2
Context of care or provider training: the impact on preventive screening practices.
Prev Med. 2005 Jun;40(6):718-24. doi: 10.1016/j.ypmed.2004.09.013.
3
[Check lists and screening--a threat against the consultation].
Lakartidningen. 2004 Apr 7;101(15-16):1412-5.
4
Implementing developmental screening.
J Pediatr Nurs. 2010 Aug;25(4):302-3. doi: 10.1016/j.pedn.2010.04.001.
5
Make each patient count.
Nurse Pract. 2008 Feb;33(2):42-7. doi: 10.1097/01.NPR.0000309105.36668.e2.
6
Ethics of prevention through vaccination.
Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):665-8.
7
Opportunistic electronic reminders. Improving performance of preventive care in general practice.
Aust Fam Physician. 2004 Jan-Feb;33(1-2):87-90.
8
Individually based preventive medical recommendations - are they sustainable and responsible? A call for ethical reflection.
Scand J Prim Health Care. 2005 Jun;23(2):65-7. doi: 10.1080/02813430510018518.
9
Practice guidelines: role of internists and primary care physicians.
Med Clin North Am. 2004 Sep;88(5):1369-80, xiii. doi: 10.1016/j.mcna.2004.04.017.
10
Screening of HIV-infected patients for non-AIDS-related morbidity: an evidence-based model of practice.
Sex Health. 2011 Mar;8(1):30-42. doi: 10.1071/SH10021.
引用本文的文献
1
Expectations about check-up examinations among Swiss residents: A nationwide population-based cross-sectional survey.
PLoS One. 2021 Jul 21;16(7):e0254700. doi: 10.1371/journal.pone.0254700. eCollection 2021.
2
Why is quaternary prevention important in prevention?
Rev Saude Publica. 2017 Dec 4;51:116. doi: 10.11606/S1518-8787.2017051000041.
3
The effect of a test ordering software intervention on the prescription of unnecessary laboratory tests - a randomized controlled trial.
BMC Med Inform Decis Mak. 2017 Feb 20;17(1):20. doi: 10.1186/s12911-017-0416-6.
4
Patients' estimations of the importance of preventive health services: a nationwide, population-based cross-sectional study in Portugal.
BMJ Open. 2016 Oct 5;6(10):e011755. doi: 10.1136/bmjopen-2016-011755.
5
Conceptual issues for screening in the genomic era - time for an update?
Epidemiol Biostat Public Health. 2014 Dec 11;11(4). doi: 10.2427/9944.
6
A population-based nationwide cross-sectional study on preventive health services utilization in Portugal--what services (and frequencies) are deemed necessary by patients?
PLoS One. 2013 Nov 21;8(11):e81256. doi: 10.1371/journal.pone.0081256. eCollection 2013.
7
Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial.
Trials. 2013 Nov 13;14:385. doi: 10.1186/1745-6215-14-385.
8
Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.
PLoS One. 2013 Jul 26;8(7):e67611. doi: 10.1371/journal.pone.0067611. Print 2013.
9
Recommendations for returning genomic incidental findings? We need to talk!
Genet Med. 2013 Nov;15(11):854-9. doi: 10.1038/gim.2013.113. Epub 2013 Aug 1.
10
Investigating the role of the general practitioner in cancer prevention: a mixed methods study.
BMC Fam Pract. 2013 May 7;14:58. doi: 10.1186/1471-2296-14-58.
本文引用的文献
1
A matter of heart: the general practitioner consultation in an evidence-based world.
Scand J Prim Health Care. 2003 Mar;21(1):3-9. doi: 10.1080/02813430310000483.
2
Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented.
BMJ. 2003 Apr 26;326(7395):901. doi: 10.1136/bmj.326.7395.901.
3
Screening for cancer with computed tomography.
BMJ. 2003 Apr 26;326(7395):894-5. doi: 10.1136/bmj.326.7395.894.
4
Ultrasound screening in pregnancy: advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas.
Soc Sci Med. 2003 May;56(10):2045-57. doi: 10.1016/s0277-9536(02)00200-9.
5
Primary care: is there enough time for prevention?
Am J Public Health. 2003 Apr;93(4):635-41. doi: 10.2105/ajph.93.4.635.
6
The arrogance of preventive medicine.
CMAJ. 2002 Aug 20;167(4):363-4.
7
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
8
Screening for cardiovascular risk: public health imperative or matter for individual informed choice?
BMJ. 2002 Jul 13;325(7355):78-80. doi: 10.1136/bmj.325.7355.78.
9
Risk factor thresholds: their existence under scrutiny.
BMJ. 2002 Jun 29;324(7353):1570-6. doi: 10.1136/bmj.324.7353.1570.
10
Physicians' and patients' choices in evidence based practice.
BMJ. 2002 Jun 8;324(7350):1350. doi: 10.1136/bmj.324.7350.1350.
Zotero 插件